Skip to main content
Premium Trial:

Request an Annual Quote

One New RNAi-Related Patent Application Published By US Patent Office

Premium

Title: RNAi-Based Inhibitory Oligonucleotides. Number: 20040077082. Filed: Oct. 18, 2002. Lead Inventor: Richard Koehn, Salus Therapeutics (Genta).

According to the patent application’s abstract, the invention “discloses a class of sequence-specific oligonucleotides for use in silencing genes. Specifically, the invention includes targetable oligonucleotides composed of RNA, DNA, nucleic acid analogs, or some combination … which have a configuration such that their introduction to a solution, cell, tissue, or organism containing the target gene causes silencing of the gene to which they are targeted,” the abstract adds.

“The invention also includes methods of silencing a gene by exposing a solution, cell, tissue, or organism with a compound comprising an oligonucleotide of the invention,” the abstract states. “Additionally, the invention provides recombinant vectors comprising nucleic acid molecules that code for the targeted oligonucleotides of the invention.”

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.